JerMa88/BMC_Womens_Health_Peer_Reviews huggingface dataset:
Title: Perceptions and experiences of women with premature ovarian insufficiency about sexual
health and reproductive health
Version: 4 Date: 10 Dec 2020
Reviewer's report:
The article is quite interesting but needs some adjustments
In the abstract explain the acronym SHR
Table 2 can be excluded as it does not add anything and its content is in the text
Although it is a qualitative analysis some words can be very strong for statements like turmoil
and threat
In discussion the author's name must be in uppercase ( benetti-pinto)
In the limitations and suggestions you just make suggestions and don't show your limitations
I think it would be interesting to present in the discussion more data on cultural and religious
diversity
Title: Perceptions and experiences of women with premature ovarian insufficiency about sexual
health and reproductive health
Version: 4 Date: 10 Dec 2020
Reviewer's report:
A good study of SRH has been performed in patients with POF but requires some corrections:
title: Perceptions and experiences of women with premature ovarian insufficiency about sexual
health and reproductive health
background:
-In  background the main issue (health, sex and fertility in patients with premature ovarian
failure) has not been sufficiently addressed.
- Study gap is not justified.
- Why qualitative study? Please justify the study type.
methods:
- What was the type of qualitative study?
What was the main study question?
Results:
- what were themes?
-Please delete the first paragraph of the "Data Trustworthiness" in page 5 and refer to a reference
at the end of this section.
-What’s the meaning of “the size of menopause” in page 7?
-Please delete the phrase "who had suffered from POI" in pages 16 & 26.
-Marriage? Cohabitation is a special relationship. The content of this subcategory isn’t congruent
with the cohabitation (page 11).
-Isn't it better to replace the phrase "duality of feeling"  in page 12 with "ambivalence
sensations"?
-All percents could be deleted in table 2.
-Please write themes in table 3 and in the text.
- This isn't done in this study: "have been conducted to investigate the consequences of POI on
quality of life,  mental and sexual health of women" in the section "The strength of this study"
in page: 17.
Title: Prevalence and factors associated with modern contraceptives utilization among female
adolescents in Uganda
Version: 1 Date: 09 Dec 2020
Reviewer's report:
This is an interesting study.
Comments:
Abstract: Indicate the design of the study in the methods.
Methods:
-Please explain what was the design of your study (cross-sectional? Retrospective) it not clear
(See abstract). Elaborate more on MEASURE DHS project please
-It is not clear if the part of the data about use of contraceptive was collected at the DHS project
or you added as a part of the study
-Make sure you explain your inclusion criteria more explicitly
-I do not think table 1 is necessary?
Discussion:
-With regard to contraption utilization rate, please add more studies to show the worldwide
context as well not only Africa
-Line 223:Please cite the following papers:
Bardaweel et al. Current knowledge, attitude, and patterns of oral contraceptives utilization
among women in Jordan. 2015. BMC women’s health Journal
-Line 224: Please cite the following papers:
Bardaweel et al. Impediments to use of oral contraceptives among refugee women in camps,
Jordan. 2018. Women and Health Journal
Editorial comments: attached as tracked changes
Title: Prevalence and factors associated with modern contraceptives utilization among female
adolescents in Uganda
Version: 1 Date: 25 Dec 2020
Reviewer:  Jerome Kabakyenga
Reviewer's report:
Good study highlighting issues with contraceptive use among the 15-19 adolescents.
The Finding of 9.4% contraceptive use in this age group is what is already known according
to the UDHS 2016.
Comparison of this Contraceptive use  among this age group with with other countries is good
but it would also be informative to compare this finding (in discussion) with contracetive use in
the other age groups within the 15-49 age range.
There is need for authors to explain the differences in the numbers of participants:
4264 in Table 2  and 5408 in table 3.
There are big differences in the different regions why did the authors opt to use the 4 regions
instead of 15 regions used in the UDHS?
In UDHS the wealth quintiles were used what was the rationale of the authors using a diffent
wealth categorization?
Title: Development and validation of a short version of the Female Sexual Function Index in
the Spanish population
Version: 2 Date: 08 Dec 2020
Reviewer:  Erdinç Sar#do#an
Reviewer's report:
Dear authors,
I think that the work is original and well-design. Moreover, it could be useful in clinical approach
in Spanish speaking countries. I recommend of accepting this high quality article for publication.
However, I have a couple of recommendations for improving the manuscript:
1. How long do original version and short versions with 6 and 9 items of FSFI take
approximately? (Please indicate the rationale in the background section.)
2. What are the advantages and disadvantages of alternative versions according to each other?
(Kindly have some word in the discussion section.)
Best regards.
Title: Psychological predictors of intention and avoidance of attending organized
mammography screening in Norway - applying the Extended Parallel Process Model
Version: 2 Date: 11 Nov 2020
Reviewer's report:
General comments
This is a well-performed study with the findings relevant for Norway and other countries offering
organized mammographic screening. The authors aimed to explore how psychological factors
affected defensive avoidance of breast cancer screening and intention to attend mammography.
The study showed that defensive avoidance of breast cancer screening and intention to
attend mammography were predicted by different psychological factors, which resulted in
the recommendations for mammography screening campaigns. The main limitations might be
associated with the small study sample and inclusion of women under 50 years, who are typically
not eligible for breast cancer screening in Norway.
Specific comments
Abstract
Methods: It would probably be clearer for the readers what kind of sample was employed if
you could add the age range of the included women, as well as the study period. Multivariate
analyses and models should be described more specifically in this section.
Results: I suggest adding the measures or numbers associated with the obtained results.
Background
Paragraph 1: According to the latest publication (Cancer in Norway 2019 with data from 2018),
breast cancer is the second leading cause of cancer deaths in women in Norway, while the most
deadly cancers for the whole (both female and male) population in Norway are lung, colon and
prostate cancers. Please update the reference and information.
Paragraph 5, first sentence: Please include the references to all these studies you mention in the
statement.
Methods
Design and sampling
Please state if the ethical approval was obtained and what kind of informed consent was extracted
from the women participated in the study.
Statistical analysis
I suggest listing the descriptive statistics first in this section, for example: “We obtained means
with standard deviations and/or 95% confidence intervals for PPP, III, YYY “, etc.  Please spell
out ANOVA for the readers and please specify what tests (t-tests, chi-square tests, and One-way
ANOVA tests) were used for what variables, for example “… t-test were used to compare mean
values of continuous variables, including PPP, OOO and HHH, etc. Please mention the main
outcome variable(s) in the hierarchical linear regression model and all the adjustment variables.
Results
The authors might consider moving some parts of the text describing the performance of the
hierarchical linear regression model for two main outcome variables to the Methods section
(Statistical analysis).
Discussion
In study limitations, it would be relevant to elaborate more on the variables, which could have
influenced the defensive avoidance and attendance, such as pain and discomfort associated with
mammography screening, information on pros and cons of screening mammography available
for the women, communication with the practitioners/radiographers during mammography and
recommendations from general practitioners.
Title: Psychological predictors of intention and avoidance of attending organized
mammography screening in Norway - applying the Extended Parallel Process Model
Version: 2 Date: 16 Nov 2020
Reviewer's report:
To prepare the paper for future acceptance, please consider the selection process that led to this
sample -what population does the sample represent?
Also describe more clearly why "Mammograhy frequency" should be included in the analysis
of "Intention to attend mammography".
There are some unfinished parts of the text, , e.g. on page 7 ” All methods were carried out in
accordance with relevant guidelines and regulations” Please specify what methods, guidelines
and restrictions.
Title: Evaluation of zinc and copper levels in vaginal tissues and whole blood: correlation with
age.
Version: 1 Date: 09 Dec 2020
Reviewer:  Mine Kiseli
Reviewer's report:
**The aim of investigating whether a correlation exists between the zinc and copper levels either
or both in whole blood or vaginal tissue samples ‘ Can not be clearly understood. What would
this finding add to the literature?
** It should be mentioned in the material and methods section which ethical committee had
approved the study and if possible committee’s reference number?
*The title ‘Age is a significant predictor of vaginal tissue zinc and copper levels.’ Does not relate
with the whole manuscript. As the aim is defined as to investigate zinc and copper content in
the vaginal tissue and whole blood samples, the age is just one part of the findings significant.
** The gender (female) information is unnecessary in the table 1.
** The literature consists of data reporting copper/zinc ratios and its relation with various
diseases. As the vaginal zinc containing gel has been shown to improve atrophic symptoms of
postmenopausal women, the findings of this study may be beneficial for future research. Instead
of comparing vaginal copper and zinc levels, copper/Zinc ratio can be searched. Investigation of
this ratio with the menopausal symptoms or discharge would be more elegant or comparing the
ratio in postmenopausal and premenopausal women is another option. Suppositories containing
zinc and copper in treating menopausal symptoms can be discussed additionally.
Title: Evaluation of zinc and copper levels in vaginal tissues and whole blood: correlation with
age.
Version: 1 Date: 14 Dec 2020
Reviewer's report:
1. The background of abstract section should be " In this study, we aimed to define zinc and
copper levels in the vaginal tissue and establish whether a correlation exists between the zinc
and copper levels either or both in whole blood or vaginal tissue samples and whether the finding
correlates with the age of the patient or at least with her menopausal status.
2. Introduction section is too long.
3. The first and second paragraph of introduction section might be omitted.
4. p values should be specified in Table 2.
Title: Predictive factors for failure of the levonorgestrel releasing intrauterine system in women
with heavy menstrual bleeding
Version: 1 Date: 07 Dec 2020
Reviewer's report:
I appreciated to be the reviewer of this study. HMB conservative treatment is an important
issue that we need more comprehension.  I have some suggestions to  authors that I think could
improve the paper.
Flowchart: 6 women missed follow-up, but in the results section, the authors wrote eight.
9.3% used previous LNG-IUS. What happened with these women according the previous LNG-
IUS?
Methodology:
Despite the good description of the methodology, specific diagnosis would be important to
determine the reasons for failure to treat HMB. Severe dysmenorrhea was associated with
treatment failure. This symptom can be an expression of adenomyosis and a reason for failure.
Sample size was not calculated. Authors could calculate the power to discuss the results. The
number of women is too small to apply the results as advice to women seeking treatment for
HMB.
The authors could be less emphatic in the discussion, saying that the HMB etiology, which was
not clear in this study, could change the failure rate.
I recommend a revision of the manuscript.
Reviewer’s report
Title: 
Barriers in access to healthcare for women with disabilities: A systematic review in qualitative
studies
Version: 
0 
Date: 
22 Feb 2020
Reviewer: 
Mariella Lilue
Reviewer's report:
Please include all comments for the authors in this box rather than uploading your report as an attachment.
Please only upload as attachments annotated versions of manuscripts, graphs, supporting materials or
other aspects of your report which cannot be included in a text format.
Please overwrite this text when adding your comments to the authors.
Are the methods appropriate and well described?
If not, please specify what is required in your comments to the authors.
Yes
Does the work include the necessary controls?
If not, please specify which controls are required in your comments to the authors.
Yes
Are the conclusions drawn adequately supported by the data shown?
If not, please explain in your comments to the authors.
Yes
Are you able to assess any statistics in the manuscript or would you recommend an additional
statistical review?
If an additional statistical review is recommended, please specify what aspects require further assessment
in your comments to the editors.
I am able to assess the statistics
Quality of written English
Please indicate the quality of language in the manuscript:
Acceptable
Declaration of competing interests
Please complete a declaration of competing interests, considering the following questions:
1
. 
Have you in the past five years received reimbursements, fees, funding, or salary from an
organisation that may in any way gain or lose financially from the publication of this manuscript,
either now or in the future?
2
. 
Do you hold any stocks or shares in an organisation that may in any way gain or lose financially
from the publication of this manuscript, either now or in the future?
3
. 
Do you hold or are you currently applying for any patents relating to the content of the manuscript?
4
. 
Have you received reimbursements, fees, funding, or salary from an organization that holds or has
applied for patents relating to the content of the manuscript?
5
. 
Do you have any other financial competing interests?
6
. 
Do you have any non-financial competing interests in relation to this paper?
If you can answer no to all of the above, write 'I declare that I have no competing interests' below. If your
reply is yes to any, please give details below.
'I declare that I have no competing interests'
I agree to the open peer review policy of the journal. I understand that my name will be included on my
report to the authors and, if the manuscript is accepted for publication, my named report including any
attachments I upload will be posted on the website along with the authors' responses. I agree for my report
to be made available under an Open Access Creative Commons CC-BY license
(
http://creativecommons.org/licenses/by/4.0/
). I understand that any comments which I do not wish to be
included in my named report can be included as confidential comments to the editors, which will not be
published.
I agree to the open peer review policy of the journal
Title: Changes in the regional homogeneity of resting-state magnetic resonance imaging in
perimenopausal women
Version: 2 Date: 09 Nov 2020
Reviewer's report:
Liu et al. present an interesting study on regional differences in rs fMRI between perimenopausal
women and women with regular menses, they also found these regional differences to correlate
with lower estrogen levels and higher scores on SDS and SAS. The study is of interest, but I
have a few suggestions:
1. By study design and nature of perimenopause subjects in perimenopause and control group
differ significantly by age. Whereas it is an expected difference, one should not forget that there
are many age-related changes in brain function. Therefore, it is very possible the difference in
age can be confounding the results of the study. Please adjust your analysis for age in order to
see whether the differences are still found and whether they still correlate with estrogen levels.
2. In the introduction I would urge the authors to avoid using statements about "hormone
imbalances causing cognitive impairment and other symptoms". There are multiple mechanisms
and pathologies implicated in mechanisms of cognitive impairment and it is almost impossible
to determine a primary causative agent, therefore, "associate with" is a more appropriate way
to describe these relationships.
3. Please provide more details or references on what SAS and SDS represented, maybe
supplementary material of the actual scales, what scores are considered normal, etc.
4. The manuscript overall is well written, but needs to be proofed by a native English speaker
as there is a number of grammatical and stylistic errors.
Title: Changes in the regional homogeneity of resting-state magnetic resonance imaging in
perimenopausal women
Version: 2 Date: 11 Nov 2020
Reviewer:  Natalya Semenova
Reviewer's report:
This study aims to investigate the estrogen levels and changes in functional brain areas
relationships in perimenopausal women. The authors analyzed a sufficient literature on this
issue. The results obtained in this study are of significant scientific interest. The manuscript can
be accepted for publication, but it is necessary to correct some comments.
Abstract: "20 healthy controls" should be corrected on "20 healthy women of reproductive age".
Methods:  1. Links to the Self-rating Anxiety Scale and the Self-rating Depression Scale should
be provided.
2. Please specify the country of the 3.0T MR imager origin.
3. There is no description of the estrogen level determination in the methods.
4. The reproductive age should be limited to 45 years.
Title: Prevalence and associated factors of baseline anemia among cervical cancer patients in
Tikur Anbesa Specialized Hospital, Ethiopia.
Version: 5 Date: 14 Dec 2020
Reviewer's report:
# Majority of my comments are properly addressed except the following issues which I believe
will improve the manuscript. Moreover, some grammatical and wordy sentences are still the
issue of the revised manuscript.
1. Abstract:
Background: duplication of wording: Better to be written like this
"Almost one patient with cancer in two is anemic. About 40 to 64% of cervical cancer patients
are anemic at time of presentation.  The rate of anemia increases with the use of chemotherapy,
radiotherapy, hormonal therapy and associated with poorer treatment outcome and quality of
life.
.......associated factors of baseline anemia among cervical cancer patients in Tikur Anbesa
Specialized Hospital (TASH), Ethiopia. Delete the full word of TASH on the method section
and replace it with " TASH"
2. Background:
A.  .....Cancer of cervix  ranks fourth for both incidence (6.6%) and mortality (7.5% [1]. Bracket
is missed...
B.......tissue oxygenation causes a decrease in radiosensitivity. "radiosensitivity" is not one word.
".... radio-sensitivity... instead.
C. Abbreviation/acronym usage problem is still  there in the background and method section
for "TASH and Hb"
3. Method
Thank you  for the explanation regarding cancer treatment centers in Ethiopia. If the explanation
provided is true. I prefer, " TASH is the only center providing comprehensive cancer care in
Ethiopia."  instead of
"The cancer center of the TASH is providing surgical therapy, chemotherapy, radiation therapy,
complain therapy and other supportive and palliative cares. It is the only cancer center in
Ethiopia."
4. Results
Say "Factors associated with baseline anemia among patients with cancer of cervix" instead of
"Factors of base line anemia among cervical cancer patients"
Reviewer’s report
Title: 
Predictors of HIV/AIDS Comprehensive Knowledge and Acceptance
attitude towards people living with HIV/AIDS among unmarried young females
in Uganda: A Cross-sectional Study.
Version: 
0 
Date: 
20 Feb 2020
Reviewer: 
raed abdullah
Reviewer's report:
Hello dear 
it is a great job that you had done, but i think your introduction is so long. I f you
can resume it will be better
Are the methods appropriate and well described?
If not, please specify what is required in your comments to the authors.
Yes
Does the work include the necessary controls?
If not, please specify which controls are required in your comments to the
authors.
Yes
Are the conclusions drawn adequately supported by the data shown?
If not, please explain in your comments to the authors.
Yes
Are you able to assess any statistics in the manuscript or would you
recommend an additional statistical review?
If an additional statistical review is recommended, please specify what aspects
require further assessment in your comments to the editors.
I am able to assess the statistics
Quality of written English
Please indicate the quality of language in the manuscript:
Needs some language corrections before being published
Declaration of competing interests
Please complete a declaration of competing interests, considering the following
questions:
1
. 
Have you in the past five years received reimbursements, fees, funding, or
salary from an organisation that may in any way gain or lose financially
from the publication of this manuscript, either now or in the future?
2
. 
Do you hold any stocks or shares in an organisation that may in any way
gain or lose financially from the publication of this manuscript, either now
or in the future?
3
. 
Do you hold or are you currently applying for any patents relating to the
content of the manuscript?
4
. 
Have you received reimbursements, fees, funding, or salary from an
organization that holds or has applied for patents relating to the content of
the manuscript?
5
. 
Do you have any other financial competing interests?
6
. 
Do you have any non-financial competing interests in relation to this
paper?
If you can answer no to all of the above, write 'I declare that I have no competing
interests' below. If your reply is yes to any, please give details below.
I declare that I have no competing interests
I agree to the open peer review policy of the journal. I understand that my name
will be included on my report to the authors and, if the manuscript is accepted
for publication, my named report including any attachments I upload will be
posted on the website along with the authors' responses. I agree for my report to
be made available under an Open Access Creative Commons CC-BY license
(
http://creativecommons.org/licenses/by/4.0/
). I understand that any comments
which I do not wish to be included in my named report can be included as
confidential comments to the editors, which will not be published.
I agree to the open peer review policy of the journal